Use of isoflavonoids in the treatment or prevention of postpartu

Details Use of isoflavonoids in the treatment or prevention of postpartu Use of isoflavonoids in the treatment or prevention of postpartu

1997-05-22

2000-07-04

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

424449, 424451, 424464, 424489, A61F 1300, A61K 970, A61K 920, A61K 4700

Patent

active

060835265

ABSTRACT:
A method of treating or preventing postpartum depression by administration of a composition containing one or more purified, naturally-occurring isoflavonoids.

REFERENCES:
patent: 5516528 (1996-05-01), Hughes
patent: 5569459 (1996-10-01), Shlyankevich
patent: 5589182 (1996-12-01), Tashiro
Gregoire et al. Transdermal oestrogen for treatment of severe postnatal depression. The Lancet 347: 930-33, 1996.
Klaiber et al. Estrogen therapy for severe persistent depressions in women. Arch. Gen. Psychiatry 36: 550-54, 1979.
Murray. Oestrogen and postnatal depression. The Lancet 347: 918-19, 1996.
Sichel et al. Prophylactic estrogen in recurrent postpartum affective disorder. Biol. Psychiatry 38: 814-18, 1995.

Affiliated with

Also associated with

Rating

Use of isoflavonoids in the treatment or prevention of postpartu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of isoflavonoids in the treatment or prevention of postpartu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoflavonoids in the treatment or prevention of postpartu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1483612